Expert Review of Endocrinology and Metabolism

Disparities in diabetes care among minority populations
pp. 425-427(3)
Author: Kirk, Julienne K

Anti-estrogen therapy offers new hope for ovarian cancer patients
pp. 429-431(3)

The role of lanreotide Autogel^® in the treatment of acromegaly
pp. 433-441(9)
Author: Andersen, Marianne

AIP gene in pituitary adenoma predisposition
pp. 443-450(8)
Authors: Vahteristo, Pia; Karhu, Auli

Challenges in studies of the genetic basis of Type 2 diabetes
pp. 451-459(9)
Author: Laakso, Markku

Noncoding miRNAs as key controllers of pancreatic β-cell functions
pp. 461-468(8)
Authors: Lovis, Pascal; Regazzi, Romano

Oral antidiabetic agents: how much kidney disease can we tolerate?
pp. 469-475(7)
Authors: Mayer, Christof; Holstein, Andreas; Stumvoll, Michael

Skeletal muscle AMP kinase as a target to prevent pathogenesis of Type 2 diabetes
pp. 477-485(9)
Authors: Krook, Anna; Long, Yun Chau; Zierath, Juleen R

Function of nuclear steroid receptors in apoptosis: role of ursodeoxycholic acid
pp. 487-501(15)
Authors: Amaral, Joana D; Solá, Susana; Steer, Clifford J; Rodrigues, Cecília P

Genetics and pharmacogenetics of estrogen response
pp. 503-516(14)
Authors: Carbonell Sala, Silvia; Martineti, Valentina; Carossino, Anna Maria; Brandi, Maria Luisa

Role of radiolabeled octreotide therapy in patients with metastatic neuroendocrine neoplasms
pp. 517-527(11)
Authors: Frilling, Andrea; Weber, Frank; Cicinnati, Vito; Broelsch, Christoph

Breathing disorders in Prader-Willi syndrome: the role of obesity, growth hormone treatment and upper respiratory tract infections
pp. 529-537(9)
Authors: Festen, Dederieke AM; Hokken-Koelega, Anita CS

Renal hemodynamics in overweight and obesity: pathogenetic factors and targets for intervention
pp. 539-552(14)
Authors: Kwakernaak, Arjan J; Tent, Hilde; Rook, Mieneke; Krikken, Jan A; Navis, Gerjan